Rapid Electrochemical Monitoring of Bacterial Respiration for Gram-Positive and Gram-Negative Microbes: Potential Application in Antimicrobial Susceptibility Testing.
Pragadeeshwara Rao RShalini SharmaTithi MehrotraRajashree DasRanjit KumarRachana SinghIndrajit RoyTinku BasuPublished in: Analytical chemistry (2020)
Antimicrobial resistance is a grave threat to human life. Currently used time-consuming antibiotic susceptibility test (AST) methods limit physicians in selecting proper antibiotics. Hence, we developed a rapid AST using electroanalysis with a 15 min assay time, called EAST, which is live-monitored by time-lapse microscopy video. The present work reports systematical electrochemical analysis and standardization of protocol for EAST measurement. The proposed EAST is successfully applied for Gram-positive Bacillus subtilis and Gram-negative Escherichia coli as model organisms to monitor bacterial concentration, decay kinetics in the presence of various antibiotics (ciprofloxacin, cefixime, and amoxycillin), drug efficacy, and IC50. Bacterial decay kinetics in the presence of antibiotics were validated by the colony counting method, field emission scanning electron microscopy, and atomic force microscopy image analysis. The EAST predicts the antibiotic susceptibility of bacteria within 15 min, which is a significant advantage over existing techniques that consume hours to days. The EAST was explored further by using bacteria-friendly l-lysine-functionalized cerium oxide nanoparticle coated indium tin oxide as a working electrode to observe the enhanced electron-transfer rate in the EAST. The results are very significant for future miniaturization and automation. The proposed EAST has huge potential in the development of a rapid AST device for applications in the clinical and pharmaceutical industries.
Keyphrases
- gram negative
- multidrug resistant
- escherichia coli
- antimicrobial resistance
- electron microscopy
- atomic force microscopy
- gold nanoparticles
- randomized controlled trial
- electron transfer
- primary care
- bacillus subtilis
- high throughput
- high speed
- ionic liquid
- high resolution
- adverse drug
- risk assessment
- pseudomonas aeruginosa
- climate change
- carbon nanotubes
- label free
- candida albicans
- induced pluripotent stem cells